Institutional investors purchased a net $1.3 million shares of GERN during the quarter ended March 2013 and now own 35.44% of the total shares outstanding. This is a greater percentage than is typical for companies in the Biotechnology industry and highlights that the smart money sees this stock as an important holding.
| Individual stakeholders | 7.78% |
| Mutual fund holders | 22.72% |
| Other institutional | 12.72% |